0000899243-17-024540.txt : 20171020 0000899243-17-024540.hdr.sgml : 20171020 20171020213036 ACCESSION NUMBER: 0000899243-17-024540 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171018 FILED AS OF DATE: 20171020 DATE AS OF CHANGE: 20171020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ginn Scott G CENTRAL INDEX KEY: 0001543701 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 171148026 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-18 0 0000896262 AMEDISYS INC AMED 0001543701 Ginn Scott G 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Financial Officer Common Stock 2017-10-18 4 A 0 3554 0.00 A 16416 D Common Stock 2529 I Through 401(k) Plan Stock Option (Right to Buy) 49.25 2017-10-18 4 A 0 6995 0.00 A 2027-10-18 Common Stock 6995 6995 D Restricted Stock Units 2017-10-18 4 A 0 7107 0.00 A Common Stock 7107 7107 D The Issuer awarded the Reporting Person 3,554 time-based Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of October 18, 2018, October 18, 2019, October 18, 2020 and October 18, 2021, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The information in this report is based on a plan statement dated as of September 30, 2017. The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of October 18, 2018, October 18, 2019, October 18, 2020 and October 18, 2021, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options. The RSUs awarded are subject to performance-based vesting and will vest (i) on the certification by the Compensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals for fiscal year 2018, and (ii) satisfaction of the following additional time-based vesting conditions: 25% of the RSUs will vest immediately upon the Compensation Committee's certification of achievement of the performance goals, and the remaining 75% of the RSUs will vest in equal installments on each of October 18, 2019, October 18, 2020 and October 18, 2021, assuming the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2017-10-20